The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
The Toronto-based molecular diagnostics maker also plans to enter applied markets in the near term, and ultimately point-of-care infectious disease testing.
The team identified 64 statistically significant gene-based associations with phenotypes, illustrating the value of large, deeply phenotyped cohorts.
The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.
Saga has developed a digital PCR-based technology that it says can detect circulating tumor DNA with a mutational allele frequency of 0.001 percent.
The firm said it anticipates using the financing for further commercialization and expansion of its infectious disease testing vertical, among other activities.
A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.
Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.
Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.
In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.